2017 annual financial data
Fulcrum Therapeutics 2017 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -22,993,000 USD and net income was -22,964,000 USD.
Operating cash flow was -20,074,000 USD.
Get free Fulcrum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,993,000 USD
- Net income
- -22,964,000 USD
- Operating cash flow
- -20,074,000 USD